1. Home
  2. JSPR
  3. JSPR News

Latest Jasper Therapeutics Inc. (JSPR) News on September 13, 2025

Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
JSPR

GlobeNewswire

3 months ago

Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria

Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress
JSPR

GlobeNewswire

3 months ago

Jasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress

Jasper Therapeutics (NASDAQ:JSPR) Will Have To Spend Its Cash Wisely
JSPR

Simply Wall St.

3 months ago

Jasper Therapeutics (NASDAQ:JSPR) Will Have To Spend Its Cash Wisely

Jasper Therapeutics to Present at Upcoming Investor Conferences
JSPR

GlobeNewswire

4 months ago

Jasper Therapeutics to Present at Upcoming Investor Conferences

Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
JSPR

GlobeNewswire

4 months ago

Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPR

GlobeNewswire

6 months ago

Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting
JSPR

GlobeNewswire

7 months ago

Jasper Therapeutics Announces Late-Breaking Briquilimab Presentation at the American Academy of Dermatology (AAD) Annual Meeting

Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
JSPR

GlobeNewswire

7 months ago

Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update

Jasper Therapeutics to Present at Upcoming March Investor Conferences
JSPR

GlobeNewswire

7 months ago

Jasper Therapeutics to Present at Upcoming March Investor Conferences

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPR

GlobeNewswire

7 months ago

Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference
JSPR

GlobeNewswire

7 months ago

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
JSPR

GlobeNewswire

8 months ago

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria

Jasper Therapeutics to Host Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on January 8, 2025
JSPR

GlobeNewswire

8 months ago

Jasper Therapeutics to Host Webinar to Present Preliminary Data from the BEACON Study of Briquilimab in Chronic Spontaneous Urticaria on January 8, 2025

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma
JSPR

GlobeNewswire

9 months ago

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma

We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
JSPR

Simply Wall St.

10 months ago

We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate

Jasper Therapeutics to Participate at Upcoming Investor Conferences
JSPR

GlobeNewswire

10 months ago

Jasper Therapeutics to Participate at Upcoming Investor Conferences

Analysts Bullish on Jasper Therapeutics as Briquilimab Trials Show Promise
JSPR

GuruFocus.com

10 months ago

Analysts Bullish on Jasper Therapeutics as Briquilimab Trials Show Promise

Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
JSPR

GlobeNewswire

10 months ago

Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting

Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Announces Health Canada Clearance of Clinical Trial Application for Phase 1b/2a Study of Briquilimab in Asthma

Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present at Present at Upcoming September Investor Conferences

Jasper Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Developments

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
JSPR

GuruFocus.com

a year ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
JSPR

GuruFocus.com

a year ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case
JSPR

CNW Group

a year ago

Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
JSPR

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

JSPR

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
JSPR

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

JSPR

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
JSPR

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
JSPR

PR Newswire

a year ago

NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities

JSPR

Business Wire

a year ago

Form 8.3 - Darktrace plc

JSPR

Business Wire

a year ago

Form 8.3 - International Distribution Services plc

US Supreme Court rejects Kroger challenge to Grubhub trademark win
JSPR

Reuters

a year ago

US Supreme Court rejects Kroger challenge to Grubhub trademark win

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
JSPR

Investor's Business Daily

a year ago

Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect

JSPR

GlobeNewswire

a year ago

Middlefield Canadian Income PCC: Net Asset Value(s)

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina
JSPR

Business Wire

a year ago

GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina

JSPR

Business Wire

a year ago

Form 8.3 - International Paper Company

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
JSPR

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
JSPR

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
JSPR

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally
JSPR

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
JSPR

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
JSPR

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
JSPR

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

JSPR

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation
JSPR

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024

Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present at the Jefferies Global Healthcare Conference

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments

Jasper Therapeutics Announces Briquilimab Development Program in Asthma
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Announces Briquilimab Development Program in Asthma

Jasper Therapeutics to Present at Upcoming Investor Conferences in May
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present at Upcoming Investor Conferences in May

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
JSPR

GlobeNewswire

a year ago

Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria

New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
JSPR

GlobeNewswire

a year ago

New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia

Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments

Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Forrester Research To Broadcast Its 2023 Fourth-Quarter And Full-Year Earnings Conference Call
JSPR

Business Wire

2 years ago

Forrester Research To Broadcast Its 2023 Fourth-Quarter And Full-Year Earnings Conference Call

Lifetime Brands (NASDAQ:LCUT) Is Due To Pay A Dividend Of $0.0425
JSPR

Simply Wall St.

2 years ago

Lifetime Brands (NASDAQ:LCUT) Is Due To Pay A Dividend Of $0.0425

Alerus (ALRS) Reports Q4 Earnings: What Key Metrics Have to Say
JSPR

Zacks

2 years ago

Alerus (ALRS) Reports Q4 Earnings: What Key Metrics Have to Say

Alerus (ALRS) Misses Q4 Earnings Estimates
JSPR

Zacks

2 years ago

Alerus (ALRS) Misses Q4 Earnings Estimates

W&T Offshore Beefs Up Shallow Water GoM Holdings
JSPR

Hart Energy

2 years ago

W&T Offshore Beefs Up Shallow Water GoM Holdings

5 Outstanding Small Cap Value Stocks
JSPR

Zacks

2 years ago

5 Outstanding Small Cap Value Stocks

Forrester: Global Tech Spend To Grow 5.3% In 2024, Reaching $4.7 Trillion
JSPR

PR Newswire

2 years ago

Forrester: Global Tech Spend To Grow 5.3% In 2024, Reaching $4.7 Trillion

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
JSPR

GlobeNewswire

2 years ago

Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Gritstone bio to Participate in Upcoming Investor Conference
JSPR

GlobeNewswire

2 years ago

Gritstone bio to Participate in Upcoming Investor Conference

Smart TV Platform Battle Rages At CES 2024. Amazon, Roku Make Waves.
JSPR

Investor's Business Daily

2 years ago

Smart TV Platform Battle Rages At CES 2024. Amazon, Roku Make Waves.

Eos Energy Enterprises and TETRA Technologies, Inc. Extend Partnership, Expanding Electrolyte Production Capacity
JSPR

GlobeNewswire

2 years ago

Eos Energy Enterprises and TETRA Technologies, Inc. Extend Partnership, Expanding Electrolyte Production Capacity

Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones

Jasper Therapeutics, Inc. Announces Reverse Stock Split
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics, Inc. Announces Reverse Stock Split

Eos Energy and Partner4Work Collaborate on Green Technology Career Development
JSPR

GlobeNewswire

2 years ago

Eos Energy and Partner4Work Collaborate on Green Technology Career Development

3 Gene-Editing Stocks With the Potential to Mint Millionaires
JSPR

InvestorPlace

2 years ago

3 Gene-Editing Stocks With the Potential to Mint Millionaires

West Virginia governor spars with bank over $300M debt
JSPR

American Banker

2 years ago

West Virginia governor spars with bank over $300M debt

Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
JSPR

GlobeNewswire

2 years ago

Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023

ADTRAN (ADTN) Boosts User Base With Solid Mosaic One Traction
JSPR

Zacks

2 years ago

ADTRAN (ADTN) Boosts User Base With Solid Mosaic One Traction

Adtran’s Mosaic One simplifies network operations for over 300 new customers
JSPR

Business Wire

2 years ago

Adtran’s Mosaic One simplifies network operations for over 300 new customers

Investing in Hallador Energy (NASDAQ:HNRG) three years ago would have delivered you a 964% gain
JSPR

Simply Wall St.

2 years ago

Investing in Hallador Energy (NASDAQ:HNRG) three years ago would have delivered you a 964% gain

Quad to Present at Sidoti Virtual Investor Conference December 6-7
JSPR

Business Wire

2 years ago

Quad to Present at Sidoti Virtual Investor Conference December 6-7

Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria
JSPR

GlobeNewswire

2 years ago

Jasper Announces First Patient Dosed in Phase 1b/2a Clinical Study of Briquilimab in Chronic Spontaneous Urticaria

Grindrod Shipping Holdings Ltd. Announces Date for Unaudited Financial Results for the Three Months Ended September 30, 2023
JSPR

GlobeNewswire

2 years ago

Grindrod Shipping Holdings Ltd. Announces Date for Unaudited Financial Results for the Three Months Ended September 30, 2023

Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
JSPR

GlobeNewswire

2 years ago

Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
JSPR

InvestorPlace

2 years ago

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

Institutional Venture Management XIII, LLC Trims Stake in The Honest Co Inc
JSPR

GuruFocus.com

2 years ago

Institutional Venture Management XIII, LLC Trims Stake in The Honest Co Inc

Barings Participation Investors Reports Preliminary Third Quarter 2023 Results
JSPR

Business Wire

2 years ago

Barings Participation Investors Reports Preliminary Third Quarter 2023 Results

Carter Bankshares, Inc.'s (NASDAQ:CARE) top owners are retail investors with 55% stake, while 41% is held by institutions
JSPR

Simply Wall St.

2 years ago

Carter Bankshares, Inc.'s (NASDAQ:CARE) top owners are retail investors with 55% stake, while 41% is held by institutions

JSPR

GuruFocus.com

2 years ago

Jasper Therapeutics Inc (JSPR) Reports Q3 2023 Financial Results and Business Progress

Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences
JSPR

GlobeNewswire

2 years ago

Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences

Share on Social Networks: